0
Years of Presence in Saudi Market
0
Registered Products In SFDA
Egypt–Iraq Partnership in Healthcare
The long-standing partnership between Egypt and Iraq in healthcare reflects a shared commitment to improving patient access to high-quality, affordable medicines. Building on this strong foundation, MUP proudly established its office in Iraq in 2024, strengthening its local presence to better serve the Iraqi market and act as a regional hub for neighboring countries.
Strategic Importance of Iraq
Iraq holds a unique strategic position at the crossroads of the Middle East and Levant. This location enables efficient market access, streamlined logistics, and closer engagement with regional healthcare systems, making Iraq a natural gateway for expanding pharmaceutical supply and partnerships across the region.
Key Focus Brands for the Iraqi Market
Davalindi® (Vitamin D3) tablets and ampoules for all family members, supporting bone health and immunity across all ages.
Synthecortin® (Triamcinolone Acetonide) a trusted corticosteroid for effective anti-inflammatory management.
Xoraxon® (Ceftriaxone) a reliable, high-quality antibiotic widely used in hospital and clinical settings.
Spirex Plus® (Spiramycin + Metronidazole) a well-established combination for effective management of mixed bacterial and protozoal infections, trusted by physicians in daily practice
Why MUP Is a Trusted Partner in Iraq
Consistent high-quality manufacturing meeting international standards.
Affordable availability ensures access for a wider patient population.
Well-established, trusted brands endorsed by healthcare professionals
Strong local presence with a dedicated Iraqi team and long-term commitment.
Reliable supply chain and professional medical and regulatory support.
“MUP – Trusted Quality, Caring for Every Iraqi Family”
"MUKHTAR Pharma "
Office
Office Manager
Dr. Mostafa Hamad
Email: info@mukhtar-pharma.com
Notifications